- Home
- FBIO vs RSF Comparison
FBIO vs RSF Comparison
Compare FBIO & RSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- RSF
- Stock Information
- Founded
- FBIO 2006
- RSF 2016
- Country
- FBIO United States
- RSF United States
- Employees
- FBIO N/A
- RSF N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- RSF Investment Managers
- Sector
- FBIO Health Care
- RSF Finance
- Exchange
- FBIO Nasdaq
- RSF Nasdaq
- Market Cap
- FBIO 49.1M
- RSF 52.3M
- IPO Year
- FBIO N/A
- RSF N/A
- Fundamental
- Price
- FBIO $1.80
- RSF $14.66
- Analyst Decision
- FBIO Strong Buy
- RSF
- Analyst Count
- FBIO 2
- RSF 0
- Target Price
- FBIO $21.00
- RSF N/A
- AVG Volume (30 Days)
- FBIO 229.4K
- RSF 11.8K
- Earning Date
- FBIO 08-12-2025
- RSF 01-01-0001
- Dividend Yield
- FBIO N/A
- RSF 10.61%
- EPS Growth
- FBIO N/A
- RSF N/A
- EPS
- FBIO N/A
- RSF N/A
- Revenue
- FBIO $57,784,000.00
- RSF N/A
- Revenue This Year
- FBIO $51.59
- RSF N/A
- Revenue Next Year
- FBIO $44.74
- RSF N/A
- P/E Ratio
- FBIO N/A
- RSF N/A
- Revenue Growth
- FBIO N/A
- RSF N/A
- 52 Week Low
- FBIO $1.33
- RSF $14.81
- 52 Week High
- FBIO $2.89
- RSF $16.23
- Technical
- Relative Strength Index (RSI)
- FBIO 49.69
- RSF 37.25
- Support Level
- FBIO $1.78
- RSF $14.63
- Resistance Level
- FBIO $2.15
- RSF $14.79
- Average True Range (ATR)
- FBIO 0.10
- RSF 0.08
- MACD
- FBIO -0.02
- RSF -0.00
- Stochastic Oscillator
- FBIO 18.92
- RSF 13.29
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About RSF RiverNorth Capital and Income Fund
RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.